Zhejiang Tianyu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is EZETIMIBE, with a corresponding US DMF Number 32716.
Remarkably, this DMF maintains an Active status since its submission on September 22, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 29, 2021, and payment made on October 29, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II